Compare NOTV & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | LOAN |
|---|---|---|
| Founded | 1974 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 51.9M |
| IPO Year | 1997 | 1999 |
| Metric | NOTV | LOAN |
|---|---|---|
| Price | $0.81 | $4.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 40.3K |
| Earning Date | 12-03-2025 | 10-24-2025 |
| Dividend Yield | N/A | ★ 9.81% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | ★ $513,024,000.00 | $7,138,128.00 |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $45.49 | $4.47 |
| P/E Ratio | ★ N/A | $10.13 |
| Revenue Growth | ★ 4.54 | N/A |
| 52 Week Low | $0.66 | $4.29 |
| 52 Week High | $6.48 | $6.05 |
| Indicator | NOTV | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 36.67 | 44.58 |
| Support Level | $0.84 | $4.64 |
| Resistance Level | $0.95 | $4.83 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 39.36 | 74.77 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.